BioSpace
Avsnitt

Rewriting the rules of CMV prevention

BioSpace
Dela

In this episode of Denatured, you’ll hear from Ian McGowan, Chief Medical Officer at Synklino and James Hunter, associate professor of transplantation at Oxford University. We explore transplantation and antiviral innovation and why CMV remains one of the most persistent and consequential challenges facing transplant patients today.

Host

Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests

Ian McGowan, CMO, Synklino

James Hunter, Associate Professor of Transplantation, Oxford University

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Custom Fields

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör BioSpace. Innehållet i podden är skapat av BioSpace och inte av, eller tillsammans med, Poddtoppen.